Status:
COMPLETED
Rotigotine Patch in Subjects With Advanced Stage, Idiopathic Parkinson's Disease Who Are Not Well Controlled on Levodopa
Lead Sponsor:
UCB Pharma
Conditions:
Parkinson Disease, Idiopathic
Eligibility:
All Genders
30+ years
Phase:
PHASE3
Brief Summary
Male and female patients aged ≥ 30 years with advanced stage idiopathic Parkinson's disease, not well controlled on existing levodopa will take part in a research study at approximately 82 sites in Eu...
Eligibility Criteria
Inclusion
- Advanced stage idiopathic Parkinson's disease
Exclusion
- Well controlled on levodopa
Key Trial Info
Start Date :
March 1 2004
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 1 2005
Estimated Enrollment :
506 Patients enrolled
Trial Details
Trial ID
NCT00244387
Start Date
March 1 2004
End Date
July 1 2005
Last Update
September 25 2014
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Schwarz
Monheim, Germany